346 related articles for article (PubMed ID: 30953881)
1. Anti-tubulin agents of natural origin: Targeting taxol, vinca, and colchicine binding domains.
Naaz F; Haider MR; Shafi S; Yar MS
Eur J Med Chem; 2019 Jun; 171():310-331. PubMed ID: 30953881
[TBL] [Abstract][Full Text] [Related]
2. Structural Investigation of Vinca Domain Tubulin Binders by Pharmacophore, Atom based QSAR, Docking and Molecular Dynamics Simulations.
Athar M; Lone MY; Khedkar VM; Radadiya A; Shah A; Jha PC
Comb Chem High Throughput Screen; 2017; 20(8):682-695. PubMed ID: 28486912
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in trimethoxyphenyl (TMP) based tubulin inhibitors targeting the colchicine binding site.
Li L; Jiang S; Li X; Liu Y; Su J; Chen J
Eur J Med Chem; 2018 May; 151():482-494. PubMed ID: 29649743
[TBL] [Abstract][Full Text] [Related]
4. Computational comparison of microtubule-stabilising agents laulimalide and peloruside with taxol and colchicine.
Pineda O; Farràs J; Maccari L; Manetti F; Botta M; Vilarrasa J
Bioorg Med Chem Lett; 2004 Oct; 14(19):4825-9. PubMed ID: 15341932
[TBL] [Abstract][Full Text] [Related]
5. The interaction of the B-ring of colchicine with alpha-tubulin: a novel footprinting approach.
Chaudhuri AR; Seetharamalu P; Schwarz PM; Hausheer FH; Ludueña RF
J Mol Biol; 2000 Nov; 303(5):679-92. PubMed ID: 11061968
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the cytotoxic mechanism mediated by baccatin III, the synthetic precursor of taxol.
Pengsuparp T; Kingston DG; Neidigh KA; Cordell GA; Pezzuto JM
Chem Biol Interact; 1996 Aug; 101(2):103-14. PubMed ID: 8760392
[TBL] [Abstract][Full Text] [Related]
7. Linkages between the effects of taxol, colchicine, and GTP on tubulin polymerization.
Howard WD; Timasheff SN
J Biol Chem; 1988 Jan; 263(3):1342-6. PubMed ID: 2891710
[TBL] [Abstract][Full Text] [Related]
8. BZML, a novel colchicine binding site inhibitor, overcomes multidrug resistance in A549/Taxol cells by inhibiting P-gp function and inducing mitotic catastrophe.
Bai Z; Gao M; Zhang H; Guan Q; Xu J; Li Y; Qi H; Li Z; Zuo D; Zhang W; Wu Y
Cancer Lett; 2017 Aug; 402():81-92. PubMed ID: 28576750
[TBL] [Abstract][Full Text] [Related]
9. Structures of a diverse set of colchicine binding site inhibitors in complex with tubulin provide a rationale for drug discovery.
Wang Y; Zhang H; Gigant B; Yu Y; Wu Y; Chen X; Lai Q; Yang Z; Chen Q; Yang J
FEBS J; 2016 Jan; 283(1):102-11. PubMed ID: 26462166
[TBL] [Abstract][Full Text] [Related]
10. Interaction of a fluorescent derivative of paclitaxel (Taxol) with microtubules and tubulin-colchicine.
Han Y; Chaudhary AG; Chordia MD; Sackett DL; Perez-Ramirez B; Kingston DG; Bane S
Biochemistry; 1996 Nov; 35(45):14173-83. PubMed ID: 8916903
[TBL] [Abstract][Full Text] [Related]
11. Gatorbulin-1, a distinct cyclodepsipeptide chemotype, targets a seventh tubulin pharmacological site.
Matthew S; Chen QY; Ratnayake R; Fermaintt CS; Lucena-Agell D; Bonato F; Prota AE; Lim ST; Wang X; Díaz JF; Risinger AL; Paul VJ; Oliva MÁ; Luesch H
Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33619102
[TBL] [Abstract][Full Text] [Related]
12. Taxol-induced rose microtubule polymerization in vitro and its inhibition by colchicine.
Morejohn LC; Fosket DE
J Cell Biol; 1984 Jul; 99(1 Pt 1):141-7. PubMed ID: 6145718
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and SAR requirements of adamantane-colchicine conjugates with both microtubule depolymerizing and tubulin clustering activities.
Zefirova ON; Nurieva EV; Shishov DV; Baskin II; Fuchs F; Lemcke H; Schröder F; Weiss DG; Zefirov NS; Kuznetsov SA
Bioorg Med Chem; 2011 Sep; 19(18):5529-38. PubMed ID: 21873068
[TBL] [Abstract][Full Text] [Related]
14. Novel Natural Product- and Privileged Scaffold-Based Tubulin Inhibitors Targeting the Colchicine Binding Site.
Dong M; Liu F; Zhou H; Zhai S; Yan B
Molecules; 2016 Oct; 21(10):. PubMed ID: 27754459
[TBL] [Abstract][Full Text] [Related]
15. Structural Perspective of Benzophenones Targeting Tubulin as Anticancer Agents.
Chourasia P; Asati V; Agarwal S; Kashaw V; Das R; Kashaw SK
Mini Rev Med Chem; 2023; 23(1):33-52. PubMed ID: 35657044
[TBL] [Abstract][Full Text] [Related]
16. Docking study of ligands into the colchicine binding site of tubulin.
Farce A; Loge C; Gallet S; Lebegue N; Carato P; Chavatte P; Berthelot P; Lesieur D
J Enzyme Inhib Med Chem; 2004 Dec; 19(6):541-7. PubMed ID: 15662957
[TBL] [Abstract][Full Text] [Related]
17. Exploring the size adaptability of the B ring binding zone of the colchicine site of tubulin with para-nitrogen substituted isocombretastatins.
Jiménez C; Ellahioui Y; Álvarez R; Aramburu L; Riesco A; González M; Vicente A; Dahdouh A; Ibn Mansour A; Jiménez C; Martín D; Sarmiento RG; Medarde M; Caballero E; Peláez R
Eur J Med Chem; 2015 Jul; 100():210-22. PubMed ID: 26092446
[TBL] [Abstract][Full Text] [Related]
18. A novel orally active microtubule destabilizing agent S-40 targets the colchicine-binding site and shows potent antitumor activity.
Du T; Lin S; Ji M; Xue N; Liu Y; Zhang Z; Zhang K; Zhang J; Zhang Y; Wang Q; Sheng L; Li Y; Lu D; Chen X; Xu H
Cancer Lett; 2020 Dec; 495():22-32. PubMed ID: 32931884
[TBL] [Abstract][Full Text] [Related]
19. B-ring of colchicine and its role in taxol-induced tubulin polymerization.
Ghosh Choudhury G; Maity S; Bhattacharyya B; Biswas BB
FEBS Lett; 1986 Mar; 197(1-2):31-4. PubMed ID: 2868923
[TBL] [Abstract][Full Text] [Related]
20. Insights into the mechanism of microtubule stabilization by Taxol.
Xiao H; Verdier-Pinard P; Fernandez-Fuentes N; Burd B; Angeletti R; Fiser A; Horwitz SB; Orr GA
Proc Natl Acad Sci U S A; 2006 Jul; 103(27):10166-10173. PubMed ID: 16801540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
